HYTRIN Drug Patent Profile
✉ Email this page to a colleague
When do Hytrin patents expire, and what generic alternatives are available?
Hytrin is a drug marketed by Abbott and is included in two NDAs.
The generic ingredient in HYTRIN is terazosin hydrochloride. There are twenty-four drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the terazosin hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Hytrin
A generic version of HYTRIN was approved as terazosin hydrochloride by APNAR PHARMA LP on March 30th, 1998.
Summary for HYTRIN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 260 |
Clinical Trials: | 4 |
Patent Applications: | 4,244 |
Formulation / Manufacturing: | see details |
DailyMed Link: | HYTRIN at DailyMed |
Recent Clinical Trials for HYTRIN
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University of Iowa | Phase 1 |
Michael J. Fox Foundation for Parkinson's Research | Phase 1 |
University of Iowa Institute of Clinical and Translational Sciences | Phase 1/Phase 2 |
Anatomical Therapeutic Chemical (ATC) Classes for HYTRIN
US Patents and Regulatory Information for HYTRIN
Expired US Patents for HYTRIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Abbott | HYTRIN | terazosin hydrochloride | CAPSULE;ORAL | 020347-004 | Dec 14, 1994 | ⤷ Try a Trial | ⤷ Try a Trial |
Abbott | HYTRIN | terazosin hydrochloride | TABLET;ORAL | 019057-001 | Aug 7, 1987 | ⤷ Try a Trial | ⤷ Try a Trial |
Abbott | HYTRIN | terazosin hydrochloride | TABLET;ORAL | 019057-004 | Aug 7, 1987 | ⤷ Try a Trial | ⤷ Try a Trial |
Abbott | HYTRIN | terazosin hydrochloride | TABLET;ORAL | 019057-003 | Aug 7, 1987 | ⤷ Try a Trial | ⤷ Try a Trial |
Abbott | HYTRIN | terazosin hydrochloride | CAPSULE;ORAL | 020347-003 | Dec 14, 1994 | ⤷ Try a Trial | ⤷ Try a Trial |
Abbott | HYTRIN | terazosin hydrochloride | CAPSULE;ORAL | 020347-001 | Dec 14, 1994 | ⤷ Try a Trial | ⤷ Try a Trial |
Abbott | HYTRIN | terazosin hydrochloride | CAPSULE;ORAL | 020347-002 | Dec 14, 1994 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for HYTRIN
See the table below for patents covering HYTRIN around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Philippines | 15619 | 1-(4-AMINO-6,7-DIMETHOXY-2-QUINAZOLINYL)-4-(2-TETRAHYDROFUROYL)PIPERAZINE HYDROCHLORIDE DIHYDRATE | ⤷ Try a Trial |
Ireland | 72967 | R(+)-Terazosin | ⤷ Try a Trial |
Japan | 2711230 | ⤷ Try a Trial | |
Denmark | 0536329 | ⤷ Try a Trial | |
Greece | 3021319 | ⤷ Try a Trial | |
Japan | S5427588 | 11*44AMINOO6*77DIMETHOXYY 22QUINAZORINYL**44*22 TETRAHYDROFROYL* PIPERADINE HYDROCHLORIDE DIHYDRATE | ⤷ Try a Trial |
World Intellectual Property Organization (WIPO) | 9200073 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |